Transdermal Estrogen Device And Delivery

Patent No. EP2310001 (titled "Transdermal Estrogen Device And Delivery") was filed by Noven Pharmaceuticals on Jul 9, 2009. The application was issued on Jul 1, 2015.

Patent Family

Statuses, jurisdictions and citation links are shared on request.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
3M INNOVATIVE PROPERTIES COMPANY	Mar 23, 2016	HETTSTEDT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

May 30, 2017
Communication to the parties concerning the termination of the opposition proceedings (opponent)
May 30, 2017
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
May 24, 2017
Termination of the opposition proceedings with revocation of patent
Mar 7, 2017
Advice of delivery
Mar 2, 2017
Advice of delivery
Feb 23, 2017
Advice of delivery
Feb 22, 2017
Advice of delivery
Feb 14, 2017
Acknowledgement of a document
Feb 14, 2017
Acknowledgement of a document
Feb 14, 2017
Decision of the Opposition Division and instruction
Feb 14, 2017
Decision revoking the European patent
Feb 14, 2017
Grounds for the decision (Annex) - opposition
Feb 14, 2017
Internal form - Opposition/addressees
Jul 27, 2016
Refund of fees
May 20, 2016
Communication of a notice of opposition and request to file observations
May 20, 2016
Notice of further oppositions to opponent(s)
Apr 5, 2016
Communication of a notice of opposition - first information to patent proprietor
Mar 23, 2016
(Electronic) Receipt
Mar 23, 2016
Citation in opposition procedure
Mar 23, 2016
Citation in opposition procedure
Mar 23, 2016
Citation in opposition procedure
Mar 23, 2016
Citation in opposition procedure
Mar 23, 2016
Non-patent literature cited during the opposition procedure
Mar 23, 2016
Non-patent literature cited during the opposition procedure
Mar 23, 2016
Non-patent literature cited during the opposition procedure
Mar 23, 2016
Non-patent literature cited during the opposition procedure
Mar 23, 2016
Non-patent literature cited during the opposition procedure
Mar 23, 2016
Notice of opposition
Mar 23, 2016
Notice of opposition
Mar 23, 2016
Patent document cited during the opposition procedure
Mar 23, 2016
Patent document cited during the opposition procedure
Mar 23, 2016
Patent document cited during the opposition procedure
Mar 23, 2016
Patent document cited during the opposition procedure
Mar 23, 2016
Patent document cited during the opposition procedure
Mar 23, 2016
Patent document cited during the opposition procedure
Jul 22, 2015
Refund of fees
Jul 1, 2015
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jun 5, 2015
Decision to grant a European patent
May 11, 2015
(Electronic) Receipt
May 11, 2015
Annex
May 11, 2015
Annex
May 11, 2015
Filing of the translations of the claims
May 11, 2015
French translation of claims
May 11, 2015
German translation of the claims
May 11, 2015
Letter accompanying subsequently filed items
Jan 28, 2015
Bibliographic data of the European patent application
Jan 28, 2015
Communication about intention to grant a European patent
Jan 28, 2015
Intention to grant (signatures)
Jan 28, 2015
Text intended for grant (clean copy)
Jan 28, 2015
Text intended for grant (version for approval)
Jan 6, 2015
Notification concerning the date of oral proceedings
Jan 5, 2015
Findings upon submissions relating to oral proceedings
Jan 5, 2015
Notification concerning the date of oral proceedings
Dec 22, 2014
(Electronic) Receipt
Dec 22, 2014
Findings upon submissions relating to oral proceedings
Dec 22, 2014
Letter accompanying subsequently filed items
Dec 22, 2014
Matter concerning the application
Dec 19, 2014
(Electronic) Receipt
Dec 19, 2014
Amended claims with annotations
Dec 19, 2014
Annex to the communication
Dec 19, 2014
Claims
Dec 19, 2014
Consultation by telephone/in person
Dec 19, 2014
Description
Dec 19, 2014
Letter accompanying subsequently filed items
Dec 19, 2014
Notification concerning the date of oral proceedings
Dec 19, 2014
Result of consultation by telephone/in person
Dec 19, 2014
Written submission in preparation to/during oral proceedings
Dec 17, 2014
Annex to the communication
Dec 17, 2014
Consultation by telephone/in person
Dec 17, 2014
Result of consultation by telephone/in person
Dec 15, 2014
Findings upon submissions relating to oral proceedings
Dec 12, 2014
Findings upon submissions relating to oral proceedings
Dec 11, 2014
(Electronic) Receipt
Dec 11, 2014
Amended claims with annotations
Dec 11, 2014
Claims
Dec 11, 2014
Description
Dec 11, 2014
Description
Dec 11, 2014
Letter accompanying subsequently filed items
Dec 11, 2014
Written submission in preparation to/during oral proceedings
Nov 17, 2014
CDS Clean up - amended data concerning the representative of the applicant (Association)
Nov 11, 2014
Submission concerning representation
Sep 23, 2014
Advice of delivery
Sep 18, 2014
Acknowledgement of a document
Sep 11, 2014
Acknowledgement of a document
Sep 11, 2014
Annex to the communication
Sep 11, 2014
Preparation for oral proceedings
Sep 11, 2014
Summons to attend oral proceedings
Jan 16, 2014
(Electronic) Receipt
Jan 16, 2014
Amended claims with annotations
Jan 16, 2014
Claims
Jan 16, 2014
Letter accompanying subsequently filed items
Jan 16, 2014
Reply to communication from the Examining Division
Oct 24, 2013
Grant of extension of time limit (examination procedure)
Oct 21, 2013
(Electronic) Receipt
Oct 21, 2013
Letter accompanying subsequently filed items
Oct 21, 2013
Request for extension of time limit to communication from the Examining Division
Jul 15, 2013
Annex to the communication
Jul 15, 2013
Communication from the Examining Division
Jul 12, 2013
Brief communication to applicant/representative
May 27, 2013
Annex to the communication
May 27, 2013
Communication from the Examining Division
Dec 14, 2012
Communication of amended entries concerning the representative
Nov 28, 2012
Submission concerning change of applicant's representative
Nov 22, 2012
Submission concerning change of applicant's representative
May 30, 2011
(Electronic) Receipt
May 30, 2011
Amended claims filed after receipt of (European) search report
May 30, 2011
Amended claims with annotations
May 30, 2011
Amendments received before examination
May 30, 2011
Letter accompanying subsequently filed items
May 30, 2011
Non-patent literature cited during the examination procedure
Apr 18, 2011
Communication regarding comments on Written Opinion/amendment of application/payment of claims fee
Apr 7, 2011
Copy of the international search report
Apr 7, 2011
International publication of the international search report
Mar 23, 2011
Notification on forthcoming publication of bibliographic data
Mar 18, 2011
Copy of the international preliminary report on patentability
Feb 22, 2011
Written opinion of the ISA, boxes No. I to VIII
Feb 22, 2011
Written opinion of the ISA, cover sheet
Feb 22, 2011
Written opinion of the ISA, supplemental box
Jan 27, 2011
(Electronic) Receipt
Jan 27, 2011
Amended claims filed after receipt of (European) search report
Jan 27, 2011
Amended claims with annotations
Jan 27, 2011
Amendments received before examination
Jan 27, 2011
Request for entry into the European phase
Nov 19, 2010
Information on entry into European phase
Feb 3, 2010
Priority document (electronically transmitted)
Jan 14, 2010
Published international application - A2
Jul 20, 2009
Abstract
Jul 20, 2009
Claims
Jul 20, 2009
Description
Jul 20, 2009
Drawings

EP2310001

NOVEN PHARMACEUTICALS

Application Number: EP09790211A
Filing Date: Jul 9, 2009
Status: Revoked; Apr 15, 2019
Publication Date: Jul 1, 2015
External Links: Slate, Register , Google Patents

IP Verse

Transdermal Estrogen Device And Delivery

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2310001